<![CDATA[European Medically Assisted Reproduction Act - 2019]]>European Medically Assisted Reproduction Act - 2019

Proposed by Cllr. Julian Maverick of the Republic of Derecta

Preamble:

Understanding the principle of respect of human dignity, human rights and personal integrity as being the ethical basis of scientific discovery,

Concerned by the hypothetical discriminatory scope genetic modifications to the human gene-pool could take,

Acknowledging the benefits of the application of biotechnology in human medicine, especially concerning the alleviation and eradication of diseases,

This Act hereby establishes:

I. Definitions

For the purpose of this Act, the following definitions apply:

a) medically assisted reproduction: insemination and in vitro fertilisation,
b) insemination: the introduction of sperm into an individual willing to become pregnant's body by means other than sexual intercourse,
c) in vitro fertilisation: fertilisation of oocytes (eggs) outside an individual willing to become pregnant's body.
d) prenatal diagnosis: examination of fetal cells, a fetus or a pregnant individual to obtain information about the genetic constitution of the fetus or to detect or exclude a disease or abnormality of the fetus. Ultrasound examination forming part of the ordinary examinations pursued during pregnancy is not considered to be prenatal diagnosis pursuant to the first paragraph, and therefore does not come within the scope of this Act.
e) genetic testing: analyses of human genetic material at both the nucleic acid and chromosome levels, analyses of genetic products and their function, and examination of organs to obtain information on human genetic constitution.
f) postnatal genetic testing: it encompasses the genetic testing to diagnose a disease; presymptomatic genetic testing (predictive genetic testing and testing to determine whether or not a person is a carrier of hereditary disease that will only be expressed in later generations); laboratory genetic testing to determine sex (with the exception of laboratory genetic testing for identification purposes).
g) gene therapy: transferring of genetic material to human cells for medical purposes or to influence biological functions.
h) cloning: techniques employed to create copies of living beings that are genetically identical.
i) provision of genetic information to persons other than the patient: authorised provision by health personnel of information about hereditary disease in the family to at-risk relatives of such patient.

II. Legality of Medically Assisted Reproduction

1.Member States’ Law

Member States reserve the right to impose additional regulations and restrictions on the use of medically assisted reproduction within their territory, including with respect to the overall legality of medically assisted reproduction.

III. General Obligations:

1.INFORMATION AND CONSENT

Individuals pursuing medically assisted reproduction shall be given information on the treatment and on the medical and legal consequences it may have. Before the treatment is started, the physician providing the treatment shall ensure that written consent is provided by said individuals. If the treatment is repeated, renewed consent shall be obtained.

2.DECISIONS ON TREATMENT

The decision to undertake treatment with a view to medically assisted reproduction shall be taken by a physician. The decision shall be based on medical and psychosocial assessment of the individuals willing to undertake such treatment. Importance shall be attached to said individual/s’ capacity to provide parental care and the best interests of the child. The physician may obtain any information necessary to make an overall assessment of the individual/s.

3.GAMETE DONORS MEDICAL REGISTRY

Medical professionals responsible for the care or treatment of a person born as a result of medically assisted reproduction shall be able to access anonymised medical information, particularly with respect to hereditary diseases and genetic conditions, about the gamete donors. Member States shall establish a registry of the identity and medical records of gamete donors in order to facilitate this access.

4.GAMETES OR GONADAL TISSUE DONORS

A gametes or gonadal tissue donor shall have reached the legal age of majority. The donor must give written consent for the gametes or gonadal tissue to be used for fertilisation and for his identity to be recorded in the donor register. Consent may be withdrawn until fertilisation has taken place. A gametes or gonadal tissue donor shall not be given information on the child’s identity or their parent/s legal guardian/s.

5.SELECTION OF GAMETES DONORS

The physician who is providing the treatment shall assist in selecting a suitable gametes donor. The establishment that carries out the medically assisted reproduction procedure shall ensure that the necessary information on the procedure is registered and reported.

6.STORAGE AND IMPORT OF GAMETES OR GONADAL TISSUE

Only establishments that are specifically authorised to do so may store and import gametes or gonadal tissue. Establishments that store donated gametes or gonadal tissue shall ensure that information on the identity of gametes or gonadal tissue donors is registered and reported to a donor register. Gametes and gonadal tissue shall not be provided for medically assisted reproduction procedures after the death of the donor.

7.REGULATION OF GAMETE AND GONADAL TISSUE BANKS

Member States may lay down further provisions on the organisation of gamete and gonadal tissue banks, the use of donated gametes or gonadal tissue and the registration and reporting of information on gamete or gonadal tissue donors.

8.TREATMENT OF GAMETES BEFORE FERTILISATION

Treatment of gametes before fertilisation for the purpose of selecting the sex of the child is only permitted if the pregnant-to-be individual is has tested positive as a carrier of a sex-linked hereditary disease that is either life-threatening, severely life-limiting, or associated with severe physical or mental disability.

9.GENETIC TESTING OF EMBRYOS

Genetic testing of embryos before implantation into the womb, including tests designed to choose the sex of the child (preimplantation genetic diagnosis) may only be carried out in special cases of sex-linked hereditary diseases that are either life-threatening, severely life-limiting, or associated with severe physical or mental disability; and for which no treatment is available. If special considerations so indicate, the European Biotechnology Advisory Board mentioned in section IV may emit favourable rulings for genetic testing of embryos. Such permission may be granted for hereditary diseases that are either life-threatening, severely life-limiting or associated with severe physical or mental disability and for which no treatment is available. The embryos selected must not be genetically modified. Before preimplantation genetic diagnosis is carried out, the pregnant individual shall be given genetic counselling and information.

10.USE AND IMPLANTATION OF EMBRYOS

Implantation of embryos into the individuals from whom the oocytes were obtained shall be the preferred course of action. Member States may lay down further regulations relating to implantation of foraneous embryos into an individual’s body after in vitro fertilisation.

11.STORAGE OF EMBRYOS

Only establishments that are authorised pursuant to section III.33 to carry out medically assisted reproduction techniques may after authorisation store embryos. Embryos may not be stored for more than five years, and shall then be destroyed.

12.STORAGE OF UNFERTILISED OOCYTES AND OVARIAN TISSUE

Only establishments that are authorised pursuant to section III.33 to carry out medically assisted reproduction techniques may after authorisation store unfertilised oocytes and ovarian tissue. Unfertilised oocytes and ovarian tissue may only be stored if the conditions relating to medically assisted reproduction set out in this Act have been fulfilled or if an individual is to undergo treatment that may impair their fertility. Stored unfertilised oocytes and ovarian tissue may only be kept for as long as the interests of the individual from whom they were taken so dictate and it is considered medically justifiable. Stored unfertilised eggs and ovarian tissue shall be destroyed if said individual dies.

13.PROHIBITION AGAINST EGG DONATION AND TRANSPLANTATION OF GAMETE-PRODUCING ORGANS

The donation of oocytes or parts of oocytes by one individual to another is to be the last resort when performing medically assisted reproduction. The transplantation of gamete-producing organs and tissue from one individual to another for the purpose of treating infertility is prohibited.

14.AUTHORISATION OF METHODS OF TREATMENT

Methods of treatment that come within the scope of article I, the storage and import of gametes and gonadal tissue, cf. section III.6, treatment of gametes and gonadal tissue, cf. section III.8, and the storage of embryos and unfertilised oocytes and ovarian tissue, cf. sections III.11 and III.12, shall be authorised by Member States, and may only be used or carried out by establishments that are authorised pursuant to section III.33. Member States must notify the European Biotechnology Advisory Board of each authorisation within 24 hours of it being given; the European Biotechnology Advisory Board shall have 14 days from the point of notification to decide whether to overrule the authorisation subject to the submission of sufficient additional evidence.

15.PROHIBITION AGAINST CREATING HUMAN EMBRYOS BY CLONING

It is prohibited:
a) to create human embryos by cloning,
b) to carry out research on cell lines derived from human embryos obtained by cloning,
c) to create embryos by cloning by the technique of inserting human genetic material into an animal oocyte.

16.PROHIBITION AGAINST TECHNIQUES DESIGNED TO CREATE GENETICALLY IDENTICAL INDIVIDUALS

The use of techniques designed to create genetically identical individuals is prohibited.

17.AUTHORISATION OF PRENATAL DIAGNOSIS

Methods of examination that come within the scope of section 1.d) shall be authorised by Member States. Member States must notify the European Biotechnology Advisory Board of each authorisation within 24 hours of it being given; the European Biotechnology Advisory Board shall have 14 days from the point of notification to decide whether to overrule the authorisation subject to the submission of sufficient additional evidence.

18.CONSENT BEFORE PRENATAL DIAGNOSIS

Before prenatal diagnosis is undertaken, written consent shall be obtained from the pregnant individual who is to be examined.

19.INFORMATION AND GENETIC COUNSELLING

Before prenatal diagnosis is undertaken, individuals shall be given information on the procedure, including the fact that it is voluntary, the risk associated with carrying out the procedure, what the procedure may reveal and the consequences this may have for the child and the pregnant individual. If there are grounds to suspect a genetic disease, the pregnant individual shall also be given genetic counselling. If the procedure indicates a disease or abnormality of the fetus, the pregnant individual shall be given information and genetic counselling on the disease or abnormality in question, and on their rights and the support that is available.

20.INFORMATION ON THE SEX OF THE FETUS BEFORE THE 12TH WEEK OF PREGNANCY

Information on the sex of the a fetus conceived via medically assisted reproduction before the 12th week of pregnancy resulting from prenatal diagnosis or other examination of the fetus shall only be given if the pregnant individual is a carrier of a sex-linked disease that is either life-threatening, severely life-limiting, or associated with severe physical or mental disability.

21.PRENATAL PATERNITY TESTING

Prenatal diagnosis with a view to determining paternity and prenatal paternity testing is prohibited. This does not apply when the pregnancy may be the result of penally prosecutable acts.

22.USE OF GENETIC TESTING

Genetic testing shall only be carried out for medical purposes if it has a diagnostic or therapeutic objective.

23.Authorisation of genetic testing

Before presymptomatic genetic testing, listed in section I.e), is to be developed, Member States shall give separate authorisations for each disease or predisposition to a disease testing that is to be subject to research and development. Member States must notify the European Biotechnology Advisory Board of each authorisation within 24 hours of it being given; the European Biotechnology Advisory Board shall have 14 days from the point of notification to decide whether to overrule the authorisation subject to the submission of sufficient additional evidence.

24.CONSENT

Before presymptomatic genetic testing coming within the scope of section I.e) is carried out, written consent shall be obtained from the person who is to be examined. Before genetic testing that comes within the scope of section I.e) is carried out in the case of a child under the age of 16, written consent shall be obtained from the child’s parent/s or legal guardian/s.

25.GENETIC COUNSELLING

Before, during and after presymptomatic genetic testing coming within the scope of section I.e), the person tested shall be given genetic counselling. If the person being tested is a child under the age of 16, the child’s parent/s or legal guardian/s shall also be given genetic counselling.

26.GENETIC SCREENING AND PHARMACOGENETIC TESTING

Member States may lay down regulations relating to the authorisation of genetic screening and pharmacogenetic testing. The regulations may make exceptions from the requirements of this Act relating to written consent, genetic counselling, authorisation of establishments and reporting.

27.PRESYMPTOMATIC GENETIC TESTING OF CHILDREN

Presymptomatic genetic testing shall not be carried out on children under the age of 16 unless the test can detect a condition for which treatment may prevent or reduce damage to a child’s health. Member States must notify the European Biotechnology Advisory Board of each authorisation within 24 hours of it being given; the European Biotechnology Advisory Board shall have 14 days from the point of notification to decide whether to overrule the authorisation subject to the submission of sufficient additional evidence.

28.PROHIBITION OF THE USE OF GENETIC INFORMATION OUTSIDE THE HEALTH SERVICE

28.1. It is prohibited to request, receive, be in possession of or use information on another person obtained through presymptomatic genetic testing that comes within the scope of section I.e) or by systematic surveys of hereditary disease within a family.
28.2. It is prohibited to ask whether genetic testing or systematic surveys of hereditary disease within a family have been carried out.
28.3. The prohibitions stated in sections III.28.1 and III.28.2 do not apply to establishments that are authorised pursuant to section III.33. to carry out genetic testing that comes within the scope of section I.e) or for research purposes.
28.4. If genetic information is to be used for research purposes, consent must have been obtained from the person from whom the information was obtained.
28.5. Health personnel who need the information for diagnostic and therapeutic purposes are excepted from the prohibition stated in sections III.28.1 and III.28.2.

29.PROVISION OF GENETIC INFORMATION TO PERSONS OTHER THAN THE PATIENT

29.1. If it has been documented that a patient suffers from or has a predisposition to a hereditary disease, the patient himself may decide whether or not to inform at-risk relatives of his condition.
29.2. If the patient himself cannot or does not wish to inform at-risk relatives of this, health personnel may request the patient’s consent to inform his relatives, if the conditions stated in section III.29.4 are fulfilled and the disease is approved by member States pursuant to section III.29.5.
29.3. If the patient cannot give his consent to the provision of information to at-risk relatives by health personnel, they may nevertheless provide such information in special cases, if the conditions stated in section III.29.4 are fulfilled and the disease is approved by member States pursuant to section III.29.5.
29.4. Before health personnel contact the relatives, they shall assess whether:

  • the disease in question has life-threatening or severely life-limiting consequences for the individual’s life or health, or is associated with severe physical or mental disability
  • there is a reasonable probability that the person’s relatives are also genetically predisposed to the disease and may develop the disease later in life,
    there is a documented link between genetic predisposition to the disease and the development of the disease,
  • the genetic tests used to determine whether a person carries a genetic predisposition to the disease are reliable, and
  • there are satisfactory methods of preventing or treating the disease. If a relative is under the age of 16, only the parent/s or legal guardian/s shall be informed.

29.5. Member States will determine by regulations the diseases for which provision of genetic information to persons other than the patient is authorised.

30.CONDITIONS FOR GENE THERAPY

Gene therapy may only be used to treat diseases that are either life-threatening, severely life-limiting, or associated with severe physical or mental disability, or to prevent the occurrence of such diseases. Gene therapy on fetuses and embryos and gene therapy that may involve genetic modification of gametes is prohibited

31.AUTHORISATION OF GENE THERAPY

Methods of treatment that come within the scope of section I.g), shall be authorised by Member States. Member States may lay down regulations relating to administrative procedures. Member States must notify the European Biotechnology Advisory Board of each authorisation within 24 hours of it being given; the European Biotechnology Advisory Board shall have 14 days from the point of notification to decide whether to overrule the authorisation subject to the submission of sufficient additional evidence.

32.CONSENT

Before gene therapy is carried out, written consent shall be obtained from the person who is to be treated. Before gene therapy involving a child under the age of 16 is started, written consent shall be obtained from the child’s parent/s or legal guardian/s.

33.AUTHORISATION OF ESTABLISHMENTS

The medical application of biotechnology that requires authorisation pursuant to sections III.14, III.17, III.23 and III.31 of this Act may only take place at establishments specifically authorised by Member States for the purpose in question. The decision to authorise an establishment shall indicate which forms of medical biotechnology procedures it is allowed to carry out or commission. Member States may lay down further conditions for authorisation in their respective legislation.

34.DUTY TO PROVIDE REPORTS

Any establishment that receives authorisation pursuant to section III.33 shall submit written reports to Member States on its activities. Member States will lay down further provisions on the duty to report.

IV. European Biotechnology Advisory Board

1.APPOINTING OF MEMBERS

The Member States of the European Union will appoint a board that on request or on its own initiative can give opinions on matters that come within the scope of this Act and other questions relating to biotechnology. The opinions of the board are public unless otherwise required by the statutory duty of confidentiality. The Council may lay down further provisions on the board’s activities. This board will fall under the scope of the Commission for Internal Affairs. The Commission for Internal Affairs will immediately set forth in establishing this board with assistance from Member States following the passage of this act.

2.DURATION OF TENURES

EBAB sitting members shall not face a term limit, however Member States may remove their representative as they see fit. Representatives may also be removed by a super-majority vote of the EBAB's sitting members as defined by in the European Constitution. The board's decisions may be appealed one year after decisions have been reached provided new information is brought to light. The EBAB itself may vote to review former decisions early.

3.COMPOSITION OF THE BOARD

The EBAB shall be composed of one appointed representative per Member State from any method of the Member State's choosing, relating to the domain of biotechnology.

V. Further Provisions and Regulations

The Council may by regulations lay down further provisions to supplement and implement this Act.

]]>http://165.22.228.80:80/topic/113/european-medically-assisted-reproduction-act-2019RSS for NodeMon, 06 Apr 2026 13:59:32 GMTTue, 16 Jul 2019 11:33:30 GMT60<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Mon, 05 Aug 2019 21:13:52 GMT]]>With 4 votes for, this Act has passed.

Edward Firoux
Council Speaker and Councillor for Inquista

]]>http://165.22.228.80:80/post/525http://165.22.228.80:80/post/525Mon, 05 Aug 2019 21:13:52 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Mon, 05 Aug 2019 19:11:34 GMT]]>"Mr Speaker, should we assume this Act has passed? We would like to submit another proposal to the Council, but will wait until the EMA Act has become part of the Acquis communautaire."

]]>http://165.22.228.80:80/post/524http://165.22.228.80:80/post/524Mon, 05 Aug 2019 19:11:34 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Thu, 01 Aug 2019 00:17:21 GMT]]>On behalf of the Archrepublic of Vayinaod, I, Carita Falk, vote FOR this act.

]]>http://165.22.228.80:80/post/514http://165.22.228.80:80/post/514Thu, 01 Aug 2019 00:17:21 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Mon, 29 Jul 2019 22:55:28 GMT]]>On behalf of the Republic of Derecta, I vote FOR this Act.

HE Guillermo de Berlanga y Prieto
Councillor of the Republic of Derecta

]]>http://165.22.228.80:80/post/506http://165.22.228.80:80/post/506Mon, 29 Jul 2019 22:55:28 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Mon, 29 Jul 2019 10:40:15 GMT]]>On behalf of the Apostolic Kingdom of Angleter, I, Cllr Hrayr Cruthin, vote FOR this Act.

]]>http://165.22.228.80:80/post/503http://165.22.228.80:80/post/503Mon, 29 Jul 2019 10:40:15 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Mon, 29 Jul 2019 04:40:39 GMT]]>Voting on amendments has concluded. All three amendments have PASSED.

Voting on the final version of this Act has now begun and will conclude on 05:00 GMT August 1st, 2019.

On behalf of the Microstate of Inquista, I vote FOR this Act.

Edward Firoux
Council Speaker and Councillor for Inquista

]]>http://165.22.228.80:80/post/502http://165.22.228.80:80/post/502Mon, 29 Jul 2019 04:40:39 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Mon, 29 Jul 2019 00:31:57 GMT]]>On behalf of the Apostolic Kingdom of Angleter, I, Cllr Hrayr Cruthin, vote FOR all three amendments.

]]>http://165.22.228.80:80/post/498http://165.22.228.80:80/post/498Mon, 29 Jul 2019 00:31:57 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Sun, 28 Jul 2019 04:13:56 GMT]]>I am extending the amendment voting period for 24 hours, until 01:30 GMT July 29th, 2019.

On behalf of the Microstate of Inquista, I vote FOR all amendments.

Edward Firoux
Council Speaker and Councillor for Inquista

]]>http://165.22.228.80:80/post/496http://165.22.228.80:80/post/496Sun, 28 Jul 2019 04:13:56 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Sat, 27 Jul 2019 01:04:35 GMT]]>On behalf of the Archrepublic of Vayinaod, I vote FOR all the proposed amendments.

]]>http://165.22.228.80:80/post/494http://165.22.228.80:80/post/494Sat, 27 Jul 2019 01:04:35 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Sat, 27 Jul 2019 00:57:29 GMT]]>We vote FOR all amendments.

HE Guillermo de Berlanga y Prieto
Councillor of the Republic of Derecta

]]>http://165.22.228.80:80/post/493http://165.22.228.80:80/post/493Sat, 27 Jul 2019 00:57:29 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Fri, 26 Jul 2019 10:41:22 GMT]]>We request that our proposal to strike section III.13 also be subject to voting.

]]>http://165.22.228.80:80/post/491http://165.22.228.80:80/post/491Fri, 26 Jul 2019 10:41:22 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Fri, 26 Jul 2019 18:05:16 GMT]]>The debate has ended. Voting on amendments has begun. Voting on amendments will continueuntil 01:30 GMT July 28th, 2019.

There are THREE proposed amendments. The amendments are as followed:

AMENDMENT I: Subclause III.6
Only establishments that are specifically authorised to do so may store and import gametes or gonadal tissue. Establishments that store donated gametes or gonadal tissue shall ensure that information on the identity of gametes or gonadal tissue donors is registered and reported to a donor register. Gametes and gonadal tissue shall not be provided for medically assisted reproduction procedures after the death of the donor. Special exemptions may be authorised by Member States on a case by case basis to allow the continued preservation and use for medically assisted reproduction after the death of the donor. Member States must notify the European Biotechnology Advisory Board of each authorisation within 24 hours of it being given; the European Biotechnology Advisory Board shall have 14 days from the point of notification to decide whether to overrule the authorisation subject to the submission of sufficient additional evidence.

AMENDMENT II: Subclause III.12
Only establishments that are authorised pursuant to section III.33 to carry out medically assisted reproduction techniques may after authorisation store unfertilised oocytes and ovarian tissue. Unfertilised oocytes and ovarian tissue may only be stored if the conditions relating to medically assisted reproduction set out in this Act have been fulfilled or if an individual is to undergo treatment that may impair their fertility. Stored unfertilised oocytes and ovarian tissue may only be kept for as long as the interests of the individual from whom they were taken so dictate. Stored unfertilised eggs and ovarian tissue shall be destroyed if said individual dies. Special exemptions may be authorised by Member States on a case by case basis to allow the continued preservation and use for medically assisted reproduction after the death of the said individual. Member States must notify the European Biotechnology Advisory Board of each authorisation within 24 hours of it being given; the European Biotechnology Advisory Board shall have 14 days from the point of notification to decide whether to overrule the authorisation subject to the submission of sufficient additional evidence.

Amendment III:
13.PROHIBITION AGAINST EGG DONATION AND TRANSPLANTATION OF GAMETE-PRODUCING ORGANS
The donation of oocytes or parts of oocytes by one individual to another is to be the last resort when performing medically assisted reproduction. The transplantation of gamete-producing organs and tissue from one individual to another for the purpose of treating infertility is prohibited.

]]>http://165.22.228.80:80/post/490http://165.22.228.80:80/post/490Fri, 26 Jul 2019 18:05:16 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Mon, 22 Jul 2019 16:40:38 GMT]]>We welcome your amendments, Councillor Falk. I believe that they have helped broaden the reach of an otherwise categorical banning of the use of gametes or gonadal tissue from a deceased person for medically assisted reproduction.

However, and as former Councillor Maverick explained to Councillor Rodríguez, the intention of this proposed Act is not to regulate the commercial aspects of medically assisted reproduction but to avoid the bio-ethical concerns these practices may surface.

The same way my predecessor could not condone Councillor Rodríguez's call for a "common front" on the sharing of information pertaining to medically assisted reproduction between Member States, I myself cannot approve of an amendment being submitted with the objective to outlaw Gainful Surrogacy.

Whether there is a transactional basis to surrogacy or not is beyond the scope and intention of this Act. there is one variant of Gainful Surrogacy we believe should be, if not banned, at least discouraged, which is why we worded section III.13 as is.

Some professionals refer to the resorting to surrogacy by women that want to become mothers but do not want to go through the "inconveniences" a pregnancy entails as "social surrogacy" or "designer surrogacy". We know for a fact that, due to socio-economical or professional factors, some women believe that they can't risk getting pregnant, either because that will affect their careers or because, sorry to put it so frivolously, their body shape will be deeply altered to the point they will "no longer be attractive".

To this I say, isn't it a fact that the very existence of this kind of surrogacy does nothing but perpetuate the sexist grounds on which it lays its foundations?

This practice exploits both legal and moral loopholes currently undercutting our efforts to maintain surrogacy in particular as an ethical path towards parenthood.

But, again, I shall not approve the banning of gainful surrogacy. I believe that it would be in the best interest both of the Union and the Councillors that want to see this proposed Act prosper not to sanction the outlawing of an entire market Union-wide, and that here, national prerogative should be applied.

Thus, we propose the striking of section III.13.

May we only clarify that, at the present time, the donation of gamete producing organs and tissue from one individual to another without there being a genetic link between them is currently clinically impossible, thus why we proposed the banning of such transplantations in the same section.

]]>http://165.22.228.80:80/post/482http://165.22.228.80:80/post/482Mon, 22 Jul 2019 16:40:38 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Sun, 21 Jul 2019 23:00:45 GMT]]>I suspect that not everyone who would like to contribute to this Act has had the chance to lay out all their ideas yet, or had proper time to discuss the latest proposed amendments. Thus, I am again extending the debate another 72 hours up until 23:00 GMT July 25th, 2019.

Edward Firoux
Council Speaker and Councillor for Inquista

]]>http://165.22.228.80:80/post/481http://165.22.228.80:80/post/481Sun, 21 Jul 2019 23:00:45 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Sun, 21 Jul 2019 21:48:17 GMT]]>I'm very pleased to see the act return in a new form with improvements suggested by various Councillors included. This is the kind of legislative work Europe needs, active not stagnant. This act will have the vote of the Archrepublic, however I wish to proposed three compromise amendments.

AMENDMENT I: Subclause III.6
Only establishments that are specifically authorised to do so may store and import gametes or gonadal tissue. Establishments that store donated gametes or gonadal tissue shall ensure that information on the identity of gametes or gonadal tissue donors is registered and reported to a donor register. Gametes and gonadal tissue shall not be provided for medically assisted reproduction procedures after the death of the donor. Special exemptions may be authorised by Member States on a case by case basis to allow the continued preservation and use for medically assisted reproduction after the death of the donor. Member States must notify the European Biotechnology Advisory Board of each authorisation within 24 hours of it being given; the European Biotechnology Advisory Board shall have 14 days from the point of notification to decide whether to overrule the authorisation subject to the submission of sufficient additional evidence.

AMENDMENT II: Subclause III.12
Only establishments that are authorised pursuant to section III.33 to carry out medically assisted reproduction techniques may after authorisation store unfertilised oocytes and ovarian tissue. Unfertilised oocytes and ovarian tissue may only be stored if the conditions relating to medically assisted reproduction set out in this Act have been fulfilled or if an individual is to undergo treatment that may impair their fertility. Stored unfertilised oocytes and ovarian tissue may only be kept for as long as the interests of the individual from whom they were taken so dictate and it is considered medically justifiable. Stored unfertilised eggs and ovarian tissue shall be destroyed if said individual dies. Special exemptions may be authorised by Member States on a case by case basis to allow the continued preservation and use for medically assisted reproduction after the death of the said individual. Member States must notify the European Biotechnology Advisory Board of each authorisation within 24 hours of it being given; the European Biotechnology Advisory Board shall have 14 days from the point of notification to decide whether to overrule the authorisation subject to the submission of sufficient additional evidence.

The Archrepublic views these amendments as necessary as to allow for partners who wish to have children together still even after the death of one. There are ethical and moral reasonings as to why this should not be allowed, however these vary greatly among the various member states of the European Union. This amendment allows for oversight and the option at least for there to be interventions when deemed necessary. I give the example of recently a Vayinaodic woman who had children with her then deceased husband via medically assisted reproduction and the preservation of his sperm. Oversight is totally necessary to prevent abuse, but whether this act should be allowed should be up to each member state with the EBAB providing regulatory assistance.

Another amendment which I am still mulling over is Subclause III.13, as part of me wishes to strike the act and other part wishes to amend it to be more clear on banning Gainful Surrogacy while still leaving altruistic surrogacy untouched for member states to rule upon. I would like to hear the opinion of other Councillors before I propose such an amendment since I know there was support to strike it previously.

]]>http://165.22.228.80:80/post/480http://165.22.228.80:80/post/480Sun, 21 Jul 2019 21:48:17 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Fri, 19 Jul 2019 06:57:36 GMT]]>All comments uttered in this Council chamber since my second address are struck from the Council record. I remind Councillors to keep their discussions to matters that are relevanat to this Act.

I am pre-emptively extending the debate period for a full 72 hours, up until 23:00 GMT July 22nd, 2019.

((OOC: This OOC message will be the last OOC comment in this thread. I will not hesitate to delete any new comment that is made out of character. Angleter has explained the difference between OOC and IC in clear detail, which is much apprecaited. Let's keep the debate moving forward, thanks. Xoxo))

]]>http://165.22.228.80:80/post/475http://165.22.228.80:80/post/475Fri, 19 Jul 2019 06:57:36 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Thu, 18 Jul 2019 21:57:54 GMT]]>[OOC]

For the complete avoidance of any doubt, the entirety of this post is out-of-character. I’ll post IC later. I am speaking as myself, the man sitting behind the computer, not as Cllr Cruthin or any of my characters.

This is the basic point of IC and OOC. There is a clear and common-sense division between the universe that our characters inhabit and the real world. Therefore, Cllr de Kronstadt-y-Setia should not be referring to RL, the application feed, the list of claims, the forums, NationStates, the concept of IC, or, for that matter, the community rules of other RP regions.

None of those things exist within the RP universe; like the pages of a book, or the book itself, or the appendix to a book, or other books, don’t normally exist within the universe of a novel. For a character in a novel to start openly referring to “page 274” or “Appendix II” or “the laws of physics are different in Lord of the Rings” is breaking the fourth wall. And so it is with your posts, @Sildavia .

There is always going to be some fuzziness in terms of the RP universe beyond the EU. We can and do borrow from real-world history; we acknowledge that there is a ‘rest of the world’ beyond the boundaries of the map, but for the sake of simplicity we don’t talk about it in-character other than in relatively vague terms. It’s about getting as close as we can to a fictionalised version of the real world, within the limitations inherent to a NationStates-based community.

What is specifically stated in the Introduction thread to which Derecta linked, however, is which threads and forums are IC and which are OOC, how a post in an IC thread can be identified as OOC, and that “RP takes place in an alternate, modern-tech universe with the same physics and technologies as the real life (RL) world, but a different map”.

I’ve been prepared to turn a blind eye to your unique calendar, since I appreciate the amount of effort you’ve put into RPing your nation in different regions and on your own website, over what must be well over a decade now. However, I think you’d do well to reciprocate by being a little more forgiving, in both your IC and OOC posts, of players who lose track of your near-constant character changes. For that matter, I'd appreciate not being chased up for an explanation of my post so brusquely and in such short order.

And moreover, my willingness to overlook breaches of the rules set out in the Introduction thread (which I think is adequately signposted) does not extend much further than that. I’ll continue to turn a blind eye to the calendar, but I’m not going to take the flagrant disregard for the concept of IC and OOC that I’ve seen in this thread. Cllr de Kronstadt-y-Setia is not aware that he’s a character in an online forum RP based on a game called NationStates.

We all have our own idea of what our nations and our characters should be like, but we have to compromise that for the wider RP community to function. I value your participation in the EU, and given that your idea of Sildavia is a lot more time and effort in the making than a new RPer who has decided they want sapient dragons and a population of 4.7 billion or whatever, I’m more than happy to come to a compromise/fudge that allows you to retain things like your unique calendar, and for the rest of us to skirt around those anomalies in a way that allows us not to deal with the fact that they’re anomalies. The question is whether you’re willing to do that too.

]]>http://165.22.228.80:80/post/474http://165.22.228.80:80/post/474Thu, 18 Jul 2019 21:57:54 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Thu, 18 Jul 2019 20:13:10 GMT]]>I am saddened to hear that my, perhaps unfortunate, analogy has been interpreted by the Sildavian government as a threat. Little do they know about Derecta and Derectans, as we would never tolerate for such horrible acts to be perpetrated anywhere in the world, let alone our own soil.
Now, we didn't mean to compare internment camps to unrestricted applying of biotech in human medicine.
As anyone in this Chamber must already know, in an analogy, the relation between elements is what is compared, not the elements themselves. Put simply it's what A is to B and C is to D that's compared, this relation we wanted to point out being a Member State's disregard towards Union Law.
Nevertheless, I would like to humbly apologise to the people of Sildavia, and in particular to Councillor de Kronstadt-y-Setia, for my poor choice of words, and the using of an example, I reiterate, may have not been worthy to be considered as part of the art of oratory.

This is why I personally, not as the Councillor of Derecta, but as a regretful colleague, humbly ask for the Empire of Sildavia to reinstate their representation to the European Union.

]]>http://165.22.228.80:80/post/473http://165.22.228.80:80/post/473Thu, 18 Jul 2019 20:13:10 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Thu, 18 Jul 2019 17:19:46 GMT]]>@Sildavia

I must take now leave from you all, ladies and gentlemen of this Council, as I have received a summon to leave Europolis and attend a Government Council meeting in Kronstadt. My instructions are also to close for the moment Sildavia’s office in Europolis.

]]>http://165.22.228.80:80/post/472http://165.22.228.80:80/post/472Thu, 18 Jul 2019 17:19:46 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Thu, 18 Jul 2019 16:59:22 GMT]]>@Derecta
Apologies accepted concerning the personal matter of my political allegiance.

Concerning the “example” you offer -about internment camps- its is absolutely ludicrous and contrary to what we are defending. We are speaking of not limiting rights and freedoms, and you answer with a limitation of rights which would be considered an act of war by each and every sovereign nation.
Sildavia wouldn’t force Derectians to use the medically assisted pregnancy techniques, nor the biotechnological advancements offered by science, no matter if Derectians live in their country or in Sildavia. There is no compulsion on anybody, not even Sildavian citizens, to use them. The law protects the non-decisional third parties against a decision of their parents or legal caretakers (i.e., individuals under 18 years old, because between 18 and 22, minors have legal capacity to decide on medical treatments, among other points); but aside from this, there is no possibility of forcing treatments or tecniques on citizens or foreigners. It is, like all rights, a POSSIBILITY, not a necessity.
Your words, Sir, constitute a menace and a threat against Sildavia. Do as you like. We’ll act in consequence. Sildavia began her history well before the EU was thought, and will still exist with or without the EU. NationStates is a large world.

]]>http://165.22.228.80:80/post/470http://165.22.228.80:80/post/470Thu, 18 Jul 2019 16:59:22 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Thu, 18 Jul 2019 15:43:28 GMT]]>Councillor de Kronstadt-y-Setia, I am sorry for having mistaken your political allegiance. It was of my understanding that you had been appointed by this Conservative-Liberal coalition you mention previously ruled your country, but I ignored the fact that you are an independent.

You point out to the contradiction the right this proposed Act would give to countries currently banning medically assisted reproduction. I, yet again, defend former-Councillor Maverick's intention when proposing this Act and say that we do not intend to establish access to this therapy throughout the Union, but to regulate its application and prevent bioethics from being trodden upon. It is not the Union's mission to establish medically assisted reproduction in its Member States, but what indeed is is the protection of its citizens against danger and injustice

You have repeatedly claimed there is no legitimacy to this Act. Let me show you how there is.

Say unrestricted genetic modifying of, what according to you is not an individual, which we agree with, human zygotes and embryos not yet developing towards the fetal stage is allowed.
Say that the development of these modified, I find it hard how to define them now, "biological entities is also allowed, and that they are implanted in a pregnant-to-be individual.
Now say that the modification of this entity gave it additional advantages in the field of intelligence or physical capabilities than that of natural origin.
Wouldn't you argue that the diversity of the human race would be lost? A diversity that stems from what is commonly known as "genetic roulette", alongside contingent environmental factors? In which way is the diversity of Humanity less precious than this diversity of nations you hold so dearly?

We have already warned you, and will not take the softer stance other members of this Council have announced they'll take may this occur, but if the Empire of Sildavia has the audacity to disrespect the European Union, its laws and institutions, the Republic of Derecta will champion the fight against such blatant disregard of the rules that enable our cooperation.

Would you approve of the establishment of internment camps assembling Sildavian citizens in my country because we inscribed a clause in our Constitution stating that they're of an inferior race that should be wiped from the face of the Earth?
Would you approve my country's reneging of Union law that would protect your citizens from such barbary, just because we thought it didn't serve our selfish national interests?
I deeply regret to have had to use such a deplorable example to evidentiate the illegitimacy of the Empire of Sildavia's claims of jurisdictional superiority over Union Law, but it seems that the Sildavian delegation will never be willing to admit that they have to play by the rules we all gave each other, or else fatalities such as the ones I have described could be an everyday matter.

]]>http://165.22.228.80:80/post/469http://165.22.228.80:80/post/469Thu, 18 Jul 2019 15:43:28 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Thu, 18 Jul 2019 15:16:18 GMT]]>@Derecta
First, I must correct my illustrious colleague. I’m not and never was a “conservative”, having been since my coming of age (22 years according to Sildavian laws) a member of my country’s neutral association. I was appointed as representative to the EU -and therefore a member ot its Council- by a conservative-liberal coalition government, and I’m serving now under a socialist-liberal coalition government. So much for my “conservative persuasion”.
On the other points, you explain very well the origin of the old form my government has announced to be applied if this bill is adopted. It’s precisely in the name of democracy, the only one we know when referring to civil and political rights, the national one, that we are denouncing a limitation of those rights by a regional decision which goes too far beyond the technical cooperation which demands a union based on diversity.
Because we respect this diversity, we have nothing against other countries’ systems, religions and laws, which we fully respect... but we demand the same respect for ours. Therefore, if Sildavia is supposed to accept the limits and mechanisms foreseen in this bill, why would other countries be able to limit its provisions, even banning medically assisted reproduction, as the bill would allow them to do? The protection of human dignity and human rights would be acceptable only for the banning, but not for a major level of freedom for researchers, medical staff and citizens?
If you propose these limitations, then make them compulsory for all, in both senses (for better or for worst), or there is clearly a total contradiction in the arguments on which this kind of bills are supposed to be based.

]]>http://165.22.228.80:80/post/468http://165.22.228.80:80/post/468Thu, 18 Jul 2019 15:16:18 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Thu, 18 Jul 2019 15:07:01 GMT]]>@Sildavia
(OOC: Basicamente, esperamos que no hagas referencia a nada de la vida real, como la equivalencia entre dias/meses/años que utilizas para que progrese el tiempo en Sildavia, ni la estructura del foro, como la famosa lista "application feed" a la que te refieres. Si te fijas, todos los posts de esa lista se hacen fuera de contexto, y no tienen nada que ver con el RP que luego se hace en el resto de entradas del foro. Creo que lo que no se quiere es que se rompa la continuidad del IC, y al mencionar esos aspectos, lo haces. También, te aconsejaría que hicieras una clara distinción entre NS y este foro, como ya he te he recomendado anteriormente. Podemos ser naciones que emanan de esa página, o que se han organizado entre sí a través de una región de NS, pero, en la práctica, hay poca vinculación entre lo que ocurre en NS y este foro. El objetivo de esta página es tomar las bases que nos da NS y desarrollar lo que queremos que sea nuestra nación a través del RP sin las limitaciones impuestas por NS. Además, si te das cuenta, no nos basamos en la existencia de un planeta en el que existan otras regiones para hacer nuestro RP. Es verdad, y esto ocurría con mas frecuencia en el pasado, que hay una categoría dedicada para los posts de miembros de otras regiones de NS en la que pueden subir contenido. Sin embargo, en los casi 3 años que llevo en European Union, nunca he visto RP que involucrase al resto de regiones de NS. Aunque es verdad que, en los útltimos tiempos, se ha querido acercar estos dos aspectos de gameplay (hay una categoría dedicada a un posible futuro consenso de la política general de European Union en temas relativos a la World Assembly, esto aún no se ha implementado, y la distinción entre los dos se sigue aplicando. Creo que, por si no lo habías hecho ya al entrar en este foro, deberías referirte a esta página para mas información: Introduction to the European Union

Sin más, espero que esto te haya esclarecido por qué, al menos yo, pienso que no has respetado el contexto del todo.

P.S. Sorry guys for the enormous explanation in Spanish. Although I'm basically a native English speaker, I find that I convey messages better in Spanish, also knowing that Sildavia too is Spanish-speaking.)

]]>http://165.22.228.80:80/post/467http://165.22.228.80:80/post/467Thu, 18 Jul 2019 15:07:01 GMT<![CDATA[Reply to European Medically Assisted Reproduction Act - 2019 on Thu, 18 Jul 2019 14:55:37 GMT]]>@Derecta
On referring to the internal rules of other regions, we, Sildavians, continue to think that our countries are in a planet or world, NS, formed by regions. How could possibly the mention of other regions and their internal rules be “OOC”? Don’t they exist? Is the EU gloriously floating in Outer Space, like another Discwolrd’s A’Tuin of sorts?

]]>http://165.22.228.80:80/post/465http://165.22.228.80:80/post/465Thu, 18 Jul 2019 14:55:37 GMT